Genprex (GNPX) Common Equity (2016 - 2025)

Genprex (GNPX) has 10 years of Common Equity data on record, last reported at $767807.0 in Q3 2025.

  • For Q3 2025, Common Equity fell 53.88% year-over-year to $767807.0; the TTM value through Sep 2025 reached $767807.0, down 53.88%, while the annual FY2024 figure was $1.6 million, 78.15% down from the prior year.
  • Common Equity reached $767807.0 in Q3 2025 per GNPX's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Common Equity topped out at $50.4 million in Q1 2021 and bottomed at $767807.0 in Q3 2025.
  • Average Common Equity over 5 years is $19.8 million, with a median of $12.3 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 110.6% in 2021, then tumbled 86.47% in 2024.
  • A 5-year view of Common Equity shows it stood at $41.3 million in 2021, then plummeted by 46.04% to $22.3 million in 2022, then tumbled by 66.7% to $7.4 million in 2023, then crashed by 78.15% to $1.6 million in 2024, then tumbled by 52.61% to $767807.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $767807.0 in Q3 2025, $1.4 million in Q2 2025, and $3.9 million in Q1 2025.